You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges
|
|---|---|
| Published in |
BMJ Evidence-Based Medicine, August 2021
|
| DOI | 10.1136/bmjebm-2021-111791 |
| Pubmed ID | |
| Authors |
Maria Popp, Peter Kranke, Patrick Meybohm, Maria-Inti Metzendorf, Nicole Skoetz, Miriam S Stegemann, Stephanie Weibel |
X Demographics
The data shown below were collected from the profiles of 231 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 28 | 12% |
| United Kingdom | 26 | 11% |
| Japan | 7 | 3% |
| Canada | 5 | 2% |
| Mexico | 4 | 2% |
| Australia | 4 | 2% |
| Italy | 4 | 2% |
| Germany | 3 | 1% |
| France | 2 | <1% |
| Other | 14 | 6% |
| Unknown | 134 | 58% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 184 | 80% |
| Practitioners (doctors, other healthcare professionals) | 21 | 9% |
| Scientists | 21 | 9% |
| Science communicators (journalists, bloggers, editors) | 5 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 24 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Professor | 2 | 8% |
| Professor > Associate Professor | 2 | 8% |
| Researcher | 2 | 8% |
| Student > Bachelor | 2 | 8% |
| Librarian | 1 | 4% |
| Other | 2 | 8% |
| Unknown | 13 | 54% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 3 | 13% |
| Environmental Science | 1 | 4% |
| Veterinary Science and Veterinary Medicine | 1 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Social Sciences | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 17 | 71% |
Attention Score in Context
This research output has an Altmetric Attention Score of 251. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 April 2024.
All research outputs
#150,479
of 25,760,414 outputs
Outputs from BMJ Evidence-Based Medicine
#28
of 1,451 outputs
Outputs of similar age
#4,288
of 438,855 outputs
Outputs of similar age from BMJ Evidence-Based Medicine
#2
of 11 outputs
Altmetric has tracked 25,760,414 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,451 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,855 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.